These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

752 related articles for article (PubMed ID: 15064769)

  • 21. Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy.
    Uchibori R; Okada T; Ito T; Urabe M; Mizukami H; Kume A; Ozawa K
    J Gene Med; 2009 May; 11(5):373-81. PubMed ID: 19274675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retroviral bicistronic vectors.
    Pfützner W
    Drug News Perspect; 2008 Nov; 21(9):473-80. PubMed ID: 19180265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and construction of 2A peptide-linked multicistronic vectors.
    Szymczak-Workman AL; Vignali KM; Vignali DA
    Cold Spring Harb Protoc; 2012 Feb; 2012(2):199-204. PubMed ID: 22301656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Jedi--a novel transmembrane protein expressed in early hematopoietic cells.
    Krivtsov AV; Rozov FN; Zinovyeva MV; Hendrikx PJ; Jiang Y; Visser JW; Belyavsky AV
    J Cell Biochem; 2007 Jun; 101(3):767-84. PubMed ID: 17226770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA vaccines based on chimeric potyvirus-like particles carrying HPV16 E7 peptide (aa 44-60).
    Pokorna D; Cerovska N; Smahel M; Moravec T; Ludvikova V; Mackova J; Synkova H; Duskova M; Hozak P; Veleminsky J
    Oncol Rep; 2005 Oct; 14(4):1045-53. PubMed ID: 16142370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of posttranscriptional regulatory elements on transgene expression and virus production in the context of retrovirus vectors.
    Hlavaty J; Schittmayer M; Stracke A; Jandl G; Knapp E; Felber BK; Salmons B; Günzburg WH; Renner M
    Virology; 2005 Oct; 341(1):1-11. PubMed ID: 16054668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [An efficient tool for the construction of multiple-cistronic vectors: FMDV 2A].
    Liu BS; Liu XY; Qian C
    Sheng Wu Gong Cheng Xue Bao; 2007 Sep; 23(5):765-9. PubMed ID: 18051849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insertion of retroviral vectors in NOD/SCID repopulating human peripheral blood progenitor cells occurs preferentially in the vicinity of transcription start regions and in introns.
    Laufs S; Nagy KZ; Giordano FA; Hotz-Wagenblatt A; Zeller WJ; Fruehauf S
    Mol Ther; 2004 Nov; 10(5):874-81. PubMed ID: 15509505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retroviral vector production in the National Gene Vector Laboratory at Indiana University.
    Cornetta K; Matheson L; Ballas C
    Gene Ther; 2005 Oct; 12 Suppl 1():S28-35. PubMed ID: 16231053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reliable generation of stable high titer producer cell lines for gene therapy.
    Rattmann I; Kleff V; Feldmann A; Ludwig C; Sorg UR; Opalka B; Moritz T; Flasshove M
    Intervirology; 2007; 50(3):197-203. PubMed ID: 17283445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of transient expression system for retroviral vector production.
    Hotta A; Saito Y; Kyogoku K; Kawabe Y; Nishijima K; Kamihira M; Iijima S
    J Biosci Bioeng; 2006 Apr; 101(4):361-8. PubMed ID: 16716946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suspension packaging cell lines for the simplified generation of T-cell receptor encoding retrovirus vector particles.
    Reuss S; Biese P; Cosset FL; Takeuchi Y; Uckert W
    Gene Ther; 2007 Apr; 14(7):595-603. PubMed ID: 17235289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A heterologous system for assembly of retroviral gene vectors: intracellular budding in yeast?
    Tolmachov O
    Med Hypotheses; 2006; 67(4):807-9. PubMed ID: 16759811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serial transplantations in nonobese diabetic/severe combined immunodeficiency mice of transduced human CD34+ cord blood cells: efficient oncoretroviral gene transfer and ex vivo expansion under serum-free conditions.
    Gammaitoni L; Lucchi S; Bruno S; Tesio M; Gunetti M; Pignochino Y; Migliardi G; Lazzari L; Aglietta M; Rebulla P; Piacibello W
    Stem Cells; 2006 May; 24(5):1201-12. PubMed ID: 16410386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous expression and detection of multiple retroviral constructs in haematopoietic cells after bone marrow transplantation.
    Nyakeriga AM; Djerbi M; Malinowski MM; Grandien A
    Scand J Immunol; 2005 Jun; 61(6):545-50. PubMed ID: 15963049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations in p53 cDNA sequence introduced by retroviral vector.
    Su S; Watanabe A; Yamamoto M; Nakajima E; Miyake K; Shimada T
    Biochem Biophys Res Commun; 2006 Feb; 340(2):567-72. PubMed ID: 16380088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic engineering of virus-specific T cells with T-cell receptors recognizing minor histocompatibility antigens for clinical application.
    Griffioen M; van Egmond HM; Barnby-Porritt H; van der Hoorn MA; Hagedoorn RS; Kester MG; Schwabe N; Willemze R; Falkenburg JH; Heemskerk MH
    Haematologica; 2008 Oct; 93(10):1535-43. PubMed ID: 18768532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retroviral vector backbone immunogenicity: identification of cytotoxic T-cell epitopes in retroviral vector-packaging sequences.
    Kondo E; Akatsuka Y; Nawa A; Kuzushima K; Tsujimura K; Tanimoto M; Kodera Y; Morishima Y; Kuzuya K; Takahashi T
    Gene Ther; 2005 Feb; 12(3):252-8. PubMed ID: 15496958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of retroviral vectors for clinical use.
    Cornetta K; Reeves L; Cross S
    Methods Mol Biol; 2008; 433():17-32. PubMed ID: 18679615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hematopoietic stem cells expanded by fibroblast growth factor-1 are excellent targets for retrovirus-mediated gene delivery.
    Crcareva A; Saito T; Kunisato A; Kumano K; Suzuki T; Sakata-Yanagimoto M; Kawazu M; Stojanovic A; Kurokawa M; Ogawa S; Hirai H; Chiba S
    Exp Hematol; 2005 Dec; 33(12):1459-69. PubMed ID: 16338488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.